bNAbs could help in search for an AIDS vaccine
These bNAbs are the first to have been identified in more than a decade, and also the first to have been isolated from donors in developing countries, where the majority of new HIV infections occur.
The research paper published in Science magazine reveals that researchers at IAVI, The Scripps Research Institute, Theraclone Sciences and Monogram Biosciences will now try to exploit the newfound vulnerability on the virus to craft novel approaches to designing an AIDS vaccine.
What’s more, the global collaboration and process that led to the discovery of the two new broadly neutralizing antibodies (bNAbs) are likely to produce more such antibodies, which may in turn reveal additional vulnerabilities of HIV, adding still more vitality to the effort to develop a vaccine against AIDS.
Please note documents at the top of the article.
Author
Free to Share
Related
Malnutrition in South Africa: how one community wants resources to be spent
Health-e News
July 18, 2023
Read More » 
Cholera: vaccines can stop the spread, but the biggest deterrent is clean water
Health-e News
June 29, 2023
Read More »